PERICARDITIS
Clinical trials for PERICARDITIS explained in plain language.
Never miss a new study
Get alerted when new PERICARDITIS trials appear
Sign up with your email to follow new studies for PERICARDITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug switch aims to simplify treatment for recurring heart inflammation
Disease control Recruiting nowThis study tests how well people with well-controlled recurrent pericarditis (a condition where the heart's lining swells repeatedly) can switch from their current treatments to a new drug called KPL-387 taken alone. About 80 adults will be enrolled to find the best dosing plan a…
Matched conditions: PERICARDITIS
Phase: PHASE2 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for heart inflammation sufferers: KPL-387 trial launches
Disease control Recruiting nowThis study tests whether a new drug called KPL-387 can safely and effectively treat recurrent pericarditis, a condition where the lining around the heart becomes inflamed again and again. About 165 adults who still have symptoms despite standard treatments will take part. The goa…
Matched conditions: PERICARDITIS
Phase: PHASE2, PHASE3 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New study tracks rare heart side effects of COVID-19 shots
Knowledge-focused Recruiting nowThis study looks at people who developed heart inflammation (myocarditis or pericarditis) after getting a COVID-19 vaccine. Researchers will review medical records and follow up with participants for up to 4 years to understand long-term health outcomes. The goal is to learn more…
Matched conditions: PERICARDITIS
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated May 17, 2026 09:16 UTC
-
Rare disease mystery: european study aims to unlock secrets of CACP syndrome
Knowledge-focused Recruiting nowThis study gathers information from people with CACP syndrome, a rare genetic condition that causes joint stiffness, hip problems, and sometimes heart inflammation. Researchers aim to collect data from 15 participants across Europe to better understand how the disease progresses …
Matched conditions: PERICARDITIS
Sponsor: Meyer Children's Hospital IRCCS • Aim: Knowledge-focused
Last updated May 17, 2026 09:10 UTC